Your browser doesn't support javascript.
loading
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial.
Martinez, Fernando J; Rabe, Klaus F; Ferguson, Gary T; Wedzicha, Jadwiga A; Trivedi, Roopa; Jenkins, Martin; Darken, Patrick; Aurivillius, Magnus; Dorinsky, Paul.
Afiliação
  • Martinez FJ; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA. Electronic address: fjm2003@med.cornell.edu.
  • Rabe KF; LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA.
  • Wedzicha JA; National Heart and Lung Institute, Imperial College London, London, UK.
  • Trivedi R; AstraZeneca, Durham, NC, USA.
  • Jenkins M; AstraZeneca, Cambridge, UK.
  • Darken P; AstraZeneca, Gaithersburg, MD, USA.
  • Aurivillius M; AstraZeneca, Gothenburg, Sweden.
  • Dorinsky P; AstraZeneca, Durham, NC, USA.
Respir Med ; 185: 106509, 2021.
Article em En | MEDLINE | ID: mdl-34171789
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Budesonida / Doença Pulmonar Obstrutiva Crônica / Fumarato de Formoterol / Glicopirrolato Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Budesonida / Doença Pulmonar Obstrutiva Crônica / Fumarato de Formoterol / Glicopirrolato Idioma: En Ano de publicação: 2021 Tipo de documento: Article